Elizabeth Fox, MD, MS

faculty photo
Associate Professor of Pediatrics at the Children's Hospital of Philadelphia
Department: Pediatrics

Contact information
The Children's Hospital of Philadelphia
Division of Oncology
CTRB4016
3501 Civic Center Blvd
Philadelphia, PA 19104
Education:
BS (Laboratory Sciences)
Northeastern University, College of Pharmacy & Allied Health, Boston, MA, 1988.
MD
Pennsylvania State University College of Medicine Hershey, PA, 1993.
MS (Clinical Research)
Duke University College of Medicine Durham, NC, 2006.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

McCowage JB, Mueller S, Pratilas CA, Hargrave DR, Moertel CL,Whitlock J, Fox E, Hingorani P, Russo MW, Dasgupta K, Tseng L, Mookerjee B, Geoerger B;: Trametinib in pediatric patients with neurofibromatosis type 1 (NF-1)–associated plexiform neurofibroma: A phase I/IIa study. Am Society Clin Oncol Annual Meeting, Chicago, IL June 2018.

Geoerger B, Kang HJ, Yalon-Oren M, Marshall LV, Vezina C, Pappo AS, Laetsch TW, Petrilli AS, Ebinger M, Toporski J, Glade-Bender J, Nicholls W, Fox E, DuBois SG, Macy M, Cohn SL, Pathiraja K, Diede SJ, Ebbinghaus S, Pinto NR: KEYNOTE-051: An update on the phase 2 results of pembrolizumab (pembro) in pediatric patients (pts) with advanced melanoma or a PD-L1–positive advanced, relapsed or refractory solid tumor or lymphoma. Am Society Clin Oncol Annual Meeting; Chicago, IL June 2018.

Shulman DS, Carlowicz C, Gustafson C, Vo KT, Fox E, Muscal JA, Supko JG, Place AE, Chi SN, Shusterman S, Hanna G, O'Brien J, Ezrre S, Kao P-C, London WB, DuBois SG;: Phase I multicenter trial of CUDC-907 in children and young adults with relapsed/refractory solid tumors, CNS tumors, and lymphomas. Am Society Clin Oncol Annual Meeting, Chicago, IL June 2018.

Malempati S, Chang BH, Reid J, Liu X, Minard CG, Keller C, Fox E, Weigel BJ;: ADVL1513: Results of a phase 1 trial of entinostat, an oral histone deacetylase inhibitor, in pediatric patients with recurrent or refractory solid tumors. Am Society Clin Oncol Annual Meeting, Chicago, IL June 2018.

Desai AV, Brodeur GM, Foster J, Berg SL, Basu EM, Shusterman S, Sabnis AJ, Macy M, Yoon J, Gauvain K, Esquibel V, Maneval EC, Multani PS, FoxE.: Phase 1 study of entrectinib (RXDX-101), a TRK, ROS1, and ALK inhibitor, in children, adolescents, and young adults with recurrent or refractory solid tumors. Am Society Clin Oncol annual Meeting, Chicago, IL June 2018.

Geoerger B, Moertel CL, Whitlock J, McCowage GB, Kieran MW, Broniscer A, Hargrave DR, Hingorani P, Kilburn LB, Mueller S, Tseng L, Nebot N, Dasgupta K, Russo MW, Fox E: Phase 1 trial of trametinib alone and in combination with dabrafenib in children and adolescents with relapsed solid tumors or neurofibromatosis type 1 (NF1) progressive plexiform neurofibromas (PN). Am Society Clin Oncol Annual Meeting, Chicago,IL June 2018.

Busch C, Reid K, Balis FM, Fox E.: Volumetric absorptive microsampling devices (Mitra™) as a method of sample collection for pharmacokinetic studies in infants. American Society for Mass Spectrometry; Annual Meeting, San Diego, CA June 2018.

Balis FM, Busch C, Desai AV, Hibbitts E, Naranjo A, Bagatell R, Irwin M, Fox E: GD2 as a circulating tumor biomarker (CTB) for neuroblastoma (NBL). Am Society Clin Oncol Annual Meeting, Chicago, IL June 2018.

Schafer ES, Rau RE, Berg S, Liu X, Minard CG, D'Adamo D, Scott R, Reyderman L, Martinez G, Devarajan S, Reid JM, Fox E, Weigel BJ, Blaney SM.: A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314). Pediatric Blood and Cancer e27066. : doi: 10.1002/pbc.27066. May 2018.

Pradhan KR, Berg SL, Liu X, Minard GC, Croop J, Reid JM, Fox E, Weigel BJ : A Dose Escalation and Toxicity Study Using Pre-determined Target Concentration of Ramucirumab, an Anti-angiogenic Agent, in Children with Recurrent/ Refractory Solid Tumors: A Children’s Oncology Group/ Phase-1 Consortium Trial (ADVL1416) American Association for Cancer Research, Chicago, IL April 2018.

back to top
Last updated: 05/29/2018
The Trustees of the University of Pennsylvania